Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP654727.RAQ793FJ52louopKA3sKC90_edLS8QyRj__-DCISpS8bs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP654727.RAQ793FJ52louopKA3sKC90_edLS8QyRj__-DCISpS8bs130_assertion type Assertion NP654727.RAQ793FJ52louopKA3sKC90_edLS8QyRj__-DCISpS8bs130_head.
- NP654727.RAQ793FJ52louopKA3sKC90_edLS8QyRj__-DCISpS8bs130_assertion description "[This finding suggests that treatment with 5-aza-CdR could be a new effective therapy against human metastatic RCC and that Cx32 could be a potential target for the treatment of RCC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP654727.RAQ793FJ52louopKA3sKC90_edLS8QyRj__-DCISpS8bs130_provenance.
- NP654727.RAQ793FJ52louopKA3sKC90_edLS8QyRj__-DCISpS8bs130_assertion evidence source_evidence_literature NP654727.RAQ793FJ52louopKA3sKC90_edLS8QyRj__-DCISpS8bs130_provenance.
- NP654727.RAQ793FJ52louopKA3sKC90_edLS8QyRj__-DCISpS8bs130_assertion SIO_000772 18264126 NP654727.RAQ793FJ52louopKA3sKC90_edLS8QyRj__-DCISpS8bs130_provenance.
- NP654727.RAQ793FJ52louopKA3sKC90_edLS8QyRj__-DCISpS8bs130_assertion wasDerivedFrom befree-2016 NP654727.RAQ793FJ52louopKA3sKC90_edLS8QyRj__-DCISpS8bs130_provenance.
- NP654727.RAQ793FJ52louopKA3sKC90_edLS8QyRj__-DCISpS8bs130_assertion wasGeneratedBy ECO_0000203 NP654727.RAQ793FJ52louopKA3sKC90_edLS8QyRj__-DCISpS8bs130_provenance.